http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2753932-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e26e2cf2a200b2ceba604237c545134d |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-29 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56911 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-04 |
| filingDate | 2012-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_333d90b90faac0fa4179d85996da336c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66b6918c4572ea38797ccccf360d3282 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ff91a1daba0291bbd7d5d15f8b3e3d2 |
| publicationDate | 2014-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-2753932-A1 |
| titleOfInvention | Determination of bacterial infections of the genus rickettsia and possibly borrelia, in patients exhibiting symptoms of disease and being blood donors |
| abstract | A method for determining a possible bacterial infection in a patient which a) exhibits symptoms selected from A) specific internal symptoms of disease, and/or B) diffuse and general manifestations of disease, and/or b) is a blood donor, characterized in comprising the steps of: i) determining a) the level of a Rickettsia analyte in a sample 1 from a patient exhibiting symptoms (A), possibly combined with b) the level of a Borrelia analyte in a sample 2 from the same patient, ii) considering that the symptoms exhibited by said patient involve a) rickettsiosis if the level of the Rickettsia analyte in sample 1 is elevated, and b) borrelios if the level of the Borrelia analyte in sample 2 is elevated. For blood donors step (ii) means that whole blood and blood fractions obtained from a donor are considered to be infected with Rickettsia and/or Borrelia, respectively, when these levels are elevated in the samples. There is also described a kit containing both a Rickettsia immunoreactant and a Borrelia immunoreactant and the use of the method and kit for treating rickettsiosis and borrelios. |
| priorityDate | 2011-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.